[ Back to All articles ]

Beyond its headline-grabbing dire wolf revival that captured attention from celebrities like Sophie Turner and Tom Brady, Colossal Biosciences has achieved another significant breakthrough by successfully cloning critically endangered red wolves. With fewer than 20 red wolves remaining in the wild across North America, Colossal’s introduction of new pups from three distinct cell lines could increase the captive population’s genetic diversity by 25%. CEO Ben Lamm emphasizes that their work demonstrates how conservation can be both “restorative and visionary,” serving as a catalyst for innovation in species recovery. The company aims to reintroduce red wolves to their natural habitat through partnerships with conservation organizations and existing rewilding efforts. This initiative showcases how cutting-edge de-extinction technologies can directly address biodiversity loss, potentially establishing a model for similar projects with other endangered species while promoting habitat protection and ecological coexistence. https://starmagazine.com/colossal-biosciences-de-extinction-efforts-breathe-new-life-into-red-wolf-conservation/